by Lim Chunhan
Published 20 Feb.2024 17:23(KST)
Updated 20 Feb.2024 17:24(KST)
Myeongmun Pharmaceutical announced on the 20th that its operating profit on a consolidated basis last year was 2,361.87 million KRW, a decrease of 63.3% compared to the previous year. Sales revenue was recorded at 170,541.99 million KRW, an increase of 12.1%.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.